Decentralised Procedure Public Assessment Report Relafalk 200 mg Tabletten mit veränderter Wirkstofffreisetzung Rifamycin DE/H/
Decentralised Procedure Public Assessment Report Relafalk 200 mg Tabletten mit veränderter Wirkstofffreisetzung Rifamycin DE/H/
![JPM | Free Full-Text | The Role of the Pharmacist in Selecting the Best Choice of Medication Formulation in Dysphagic Patients JPM | Free Full-Text | The Role of the Pharmacist in Selecting the Best Choice of Medication Formulation in Dysphagic Patients](https://pub.mdpi-res.com/jpm/jpm-12-01307/article_deploy/html/images/jpm-12-01307-ag.png?1660308978)